Is It Important to Identify Extended-spectrum Beta-lactamase-producing Isolates?

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 1996 May 1

PMID 8793392

Citations 20

Authors

K Bush

Affiliations

Soon will be listed here.

Citing Articles

Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.

Bedenic B, Firis N, Elvedi-Gasparovic V, Krilanovic M, Matanovic K, Stimac I Wien Klin Wochenschr. 2016; 128(11-12):404-13.

PMID: 27220339 DOI: 10.1007/s00508-016-1005-x.

Bacterial temporal dynamics enable optimal design of antibiotic treatment.

Meredith H, Lopatkin A, Anderson D, You L PLoS Comput Biol. 2015; 11(4):e1004201.

PMID: 25905796 PMC: 4407907. DOI: 10.1371/journal.pcbi.1004201.

Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases.

Colodner R, Reznik B, Gal V, Yamazaki H, Hanaki H, Kubo R Eur J Clin Microbiol Infect Dis. 2006; 25(1):49-51.

PMID: 16416268 DOI: 10.1007/s10096-005-0074-y.

Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.

Kader A, Kumar A Ann Saudi Med. 2005; 25(3):239-42.

PMID: 16119526 PMC: 6147983. DOI: 10.5144/0256-4947.2005.239.

Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility.

Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R Eur J Clin Microbiol Infect Dis. 2005; 24(1):17-22.

PMID: 15660255 DOI: 10.1007/s10096-004-1264-8.

References

Katsanis G, Spargo J, Ferraro M, Sutton L, Jacoby G . Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol. 1994; 32(3):691-6. PMC: 263108. DOI: 10.1128/jcm.32.3.691-696.1994. View

Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S . Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983; 11(6):315-7. DOI: 10.1007/BF01641355. View

Shannon K, King A, Phillips I, Nicolas M, Philippon A . Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother. 1990; 25(3):343-51. DOI: 10.1093/jac/25.3.343. View

Jett B, Ritchie D, Reichley R, Bailey T, Sahm D . In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob Agents Chemother. 1995; 39(5):1187-90. PMC: 162708. DOI: 10.1128/AAC.39.5.1187. View

Bradford P, CHERUBIN C, Idemyor V, Rasmussen B, Bush K . Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob Agents Chemother. 1994; 38(4):761-6. PMC: 284539. DOI: 10.1128/AAC.38.4.761. View

Rice L, Willey S, Papanicolaou G, Medeiros A, Eliopoulos G, Moellering Jr R . Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990; 34(11):2193-9. PMC: 172022. DOI: 10.1128/AAC.34.11.2193. View

Rice L, Yao J, Klimm K, Eliopoulos G, Moellering Jr R . Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother. 1991; 35(6):1243-4. PMC: 284322. DOI: 10.1128/AAC.35.6.1243. View

Thomson K, Sanders C, Washington 2nd J . High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio. Antimicrob Agents Chemother. 1991; 35(5):1001-3. PMC: 245146. DOI: 10.1128/AAC.35.5.1001. View

Pangon B, Bizet C, Bure A, Pichon F, Philippon A, Regnier B . In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis. 1989; 159(5):1005-6. DOI: 10.1093/infdis/159.5.1005. View

10.

Jarlier V, Nicolas M, Fournier G, Philippon A . Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10(4):867-78. DOI: 10.1093/clinids/10.4.867. View

11.

Bauernfeind A, Horl G . Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. Infection. 1987; 15(4):257-9. DOI: 10.1007/BF01644127. View

12.

Bush K, Jacoby G, Medeiros A . A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6):1211-33. PMC: 162717. DOI: 10.1128/AAC.39.6.1211. View

13.

Jacoby G, Medeiros A . More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991; 35(9):1697-704. PMC: 245253. DOI: 10.1128/AAC.35.9.1697. View

14.

Martinez-Martinez L, Alberti S, Tomas J, Benedi V, Jacoby G . In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother. 1996; 40(2):342-8. PMC: 163113. DOI: 10.1128/AAC.40.2.342. View

15.

Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A . Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother. 1987; 20(3):323-34. DOI: 10.1093/jac/20.3.323. View

16.

Quinn J, Miyashiro D, Sahm D, Flamm R, Bush K . Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989; 33(9):1451-6. PMC: 172682. DOI: 10.1128/AAC.33.9.1451. View

17.

Weber D, Sanders C, Bakken J, Quinn J . A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J Infect Dis. 1990; 162(2):460-5. DOI: 10.1093/infdis/162.2.460. View

18.

Nuesch-Inderbinen M, Hachler H, Kayser F . Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996; 15(5):398-402. DOI: 10.1007/BF01690097. View

19.

Baquero F, Canton R, Bolmstrom A . The E-Test as an epidemiologic tool. Diagn Microbiol Infect Dis. 1992; 15(5):483-7. DOI: 10.1016/0732-8893(92)90095-b. View

20.

Thomson K, Sanders C . Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother. 1992; 36(9):1877-82. PMC: 192203. DOI: 10.1128/AAC.36.9.1877. View